FIXX
Price
$0.54
Change
+$0.01 (+1.89%)
Updated
Dec 1, 6:59 PM EST
102 days until earnings call
SRNEQ
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Feb 22, 6:59 PM EST
88 days until earnings call
Ad is loading...

Compare predictions FIXX vs SRNEQ

Header iconFIXX vs SRNEQ Comparison
Open Charts FIXX vs SRNEQBanner chart's image
Homology Medicines
Price$0.54
Change+$0.01 (+1.89%)
Volume$164.02K
CapitalizationN/A
Sorrento Therapeutics
Price$0.31
Change-$0.00 (-0.00%)
Volume$77.42M
CapitalizationN/A
View a ticker or compare two or three
FIXX vs SRNEQ Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
FIXX vs. SRNEQ commentary
Dec 03, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIXX is a Hold and SRNEQ is a Hold.

COMPARISON
Comparison
Dec 03, 2023
Stock price -- (FIXX: $0.54 vs. SRNEQ: $0.04)
Brand notoriety: FIXX: Not notable vs. SRNEQ: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FIXX: 57% vs. SRNEQ: 112%
Market capitalization -- FIXX: $32.07M vs. SRNEQ: $179.17M
FIXX [@Biotechnology] is valued at $32.07M. SRNEQ’s [@Biotechnology] market capitalization is $179.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FIXX’s FA Score shows that 1 FA rating(s) are green whileSRNEQ’s FA Score has 1 green FA rating(s).

  • FIXX’s FA Score: 1 green, 4 red.
  • SRNEQ’s FA Score: 1 green, 4 red.
According to our system of comparison, SRNEQ is a better buy in the long-term than FIXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FIXX’s TA Score shows that 4 TA indicator(s) are bullish while SRNEQ’s TA Score has 4 bullish TA indicator(s).

  • FIXX’s TA Score: 4 bullish, 4 bearish.
  • SRNEQ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SRNEQ is a better buy in the short-term than FIXX.

Price Growth

FIXX (@Biotechnology) experienced а -4.80% price change this week, while SRNEQ (@Biotechnology) price change was -15.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

FIXX is expected to report earnings on Mar 13, 2024.

SRNEQ is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FIXX with price predictions.
OPEN
A.I.dvisor published
a Summary for SRNEQ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SRNEQ($179M) has a higher market cap than FIXX($32.1M). FIXX YTD gains are higher at: -57.063 vs. SRNEQ (-95.047). FIXX has higher annual earnings (EBITDA): -116.31M vs. SRNEQ (-645.56M). FIXX has more cash in the bank: 103M vs. SRNEQ (50.3M). FIXX has less debt than SRNEQ: FIXX (28.3M) vs SRNEQ (170M). SRNEQ has higher revenues than FIXX: SRNEQ (60.7M) vs FIXX (1.96M).
FIXXSRNEQFIXX / SRNEQ
Capitalization32.1M179M18%
EBITDA-116.31M-645.56M18%
Gain YTD-57.063-95.04760%
P/E RatioN/AN/A-
Revenue1.96M60.7M3%
Total Cash103M50.3M205%
Total Debt28.3M170M17%
FUNDAMENTALS RATINGS
SRNEQ: Fundamental Ratings
SRNEQ
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FIXXSRNEQ
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 25 days ago
81%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLVRF0.180.01
+4.78%
Silver One Resources
JMPLY40.340.73
+1.85%
Johnson Matthey Public Ltd
SOMLY17.610.21
+1.21%
Secom Co Ltd
SVNDY19.700.05
+0.25%
Seven & I Holdings Co Ltd
VQSSF0.09N/A
-1.92%
VIQ Solutions